Calamos Long/Short Equity & Dynamic Income Term Trust is a closed-end investment trust that pursues current income and risk-managed capital appreciation by combining a global long/short equity strategy with allocations to income-generating securities. It actively manages its equity market exposure and overall asset mix to support regular distributions.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | -41.9 | — | -42.8 | — |
| 2023 | 11.6 | — | 11 | — |
| 2024 | 53.1 | 357.7% | 52.4 | 376% |
| 2025 | 19.9 | -62.5% | 19.3 | -63.2% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Drugs Made In America Acquisition Corp. (DMAA), Willow Lane Acquisition Corp. II (WLII), BRBI BR Partners S.A. (BRBI), FACT II Acquisition Corp (FACT), One Stop Systems, Inc. (OSS), Anavex Life Sciences Corp. (AVXL)